July 24, 2024

Lab Automation Market Propelled by Rising Adoption of Automated Processes

The Lab Automation Market is widely used across industries to optimize processes and increase productivity. Lab automation involves the use of automated instruments and software robots to perform laboratory procedures, techniques and analysis. This increases the reproducibility and quality of experiments while minimizing human errors. Lab automation products such as automated liquid handlers, microplate readers, stand-alone robots andRobotic system automation solutions are used for applications such as drug discovery, genomics, proteomics and diagnostics. The global Lab Automation Market is estimated to be valued at US$ 4,903.9 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising adoption of automated processes across industries is one of the major drivers of the Lab Automation Market. Automation helps achieve standardization, improve efficiency and reduce time consumption of repetitive tasks. Many industries are increasingly automating routine tasks to focus on high-value activities. In the lab automation sector, the demand for standalone analyzers, liquid handlers and robotic systems is growing steadily as they help minimize manual errors and sample contamination. Automated solutions such as microplate washers, ELISA systems and PCR instruments further improve throughput and reproducibility of experiments. Continuous technological advancements are also expanding the application scope of lab automation to new domains. This rising demand for automated workflows is expected to propel the Lab Automation Market substantially over the forecast period.

SWOT Analysis
Strength: Lab automation solutions offer enhanced productivity, accuracy, efficiency and reproducibility in laboratories. The adoption of lab automation streamlines operations and enables researchers to focus on high-value tasks.
Weakness: High initial investment costs associated with lab automation equipment and solutions may limit their adoption. Customization of existing lab automation workflows and integration with legacy systems can also pose challenges.
Opportunity: Growing spending on pharmaceutical R&D from industries and governments is driving demand for lab automation. In addition, the need to optimize laboratory processes and minimize errors is prompting more life sciences organizations to automate routine tasks and experiments.
Threats: Integration issues with existing infrastructure and legacy equipment can reduce the benefits of automation. Changes in regulatory standards may also impact automation product development lifecycles.

Key Takeaways

The global lab automation market is expected to witness high growth over the forecast period driven by factors such as rising R&D spending in pharmaceutical and biotechnology industries, growing focus on accelerating drug discovery process and minimizing errors, and advantages offered by automation in improving productivity and efficiency.

Regional analysis: North America currently dominates the global lab automation market and is expected to continue its leading position over the forecast period as well. Significant presence of leading lab automation solution providers and early adoption of advanced technologies among research institutions in the region supports market growth. Asia Pacific is anticipated to be the fastest growing regional market fueled by increasing R&D spending, large patient pool, and rising focus of global lab automation companies on emerging countries in the region.

Key players: Key players operating in the lab automation market are Tecan Trading AG, PerkinElmer Inc., Danaher, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Inc., Hamilton Company, COPAN Diagnostics Inc., Abbott, Merck KGaA, F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, UiPath, and Porvair Sciences, SPT Labtech Ltd, Endress+Hauser Group Services AG, Automata, accroma, Molecular Devices, LLC, Beckman Coulter, Inc., BD, Reshape Biotech, Peak Analysis & Automation. The prominent players are focusing on new product launches, partnerships, and expansions to gain a competitive edge in the market.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it

Get more insights on this topic:

Third Generation Sequencing Market

Assistive Technology Market

Macrophage Marker Market